EUVIMED · CrossrefJournal
Blood Advances
ISSN 2473-9529 · American Society of Hematology
Latest articles
Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial
A phase 2a randomized study to evaluate sapablursen in patients with non-transfusion-dependent β-thalassemia intermedia
A CRISPR-based humanized model reveals a cooperative role of STAG2 loss in familial GATA2-deficient MDS progression
Systematic review and meta-analysis of hypersensitivity reactions after high-dose IV iron
A synthetic, small-molecule, allosteric inhibitor of human factor XIa for thrombosis
Survival improvement of patients with DLBCL treated with third-line and beyond in the recent era in the Czech Republic
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders
Murine model for congenital dyserythropoietic anemia type I
Association between patient-reported symptoms and clinical outcomes in R/R CLL
PhenX Toolkit measurement protocols for sickle cell disease pain
Real-world implementation, feasibility and early effectiveness of blinatumomab for pediatric B-ALL in lower-middle-income countries
Age- and sex-adjusted genomic differences between Korean and Beat AML cohorts
Factors associated with recurrent episodes of acute chest syndrome in adult patients with sickle cell disease
Teclistamab and daratumumab immune-based doublet therapy for relapsed/refractory multiple myeloma: the TRIMM-2 study
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis
Thrombin-antithrombin complex and fibrinogen predict microangiopathic acute kidney injury in patients with traumatic injuries
Markedly increased risk of myeloid neoplasia among clonal hematopoiesis carriers with multiple TET2 mutations
Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas
Impact of cytoreductive therapy in myeloproliferative neoplasm–associated splanchnic vein thrombosis
Phase 1, open-label, multicenter study of sovleplenib (HMPL-523) in patients with relapsed or refractory lymphoma
Diagnostic accuracy of fat pad sampling and bone marrow biopsy for AL amyloidosis: a systematic review and meta-analysis
Synthetic lethality in TP53 -mutated AML
Discontinuation of targeted therapy in histiocytic neoplasms with durable responses: the DOTT-HN study
Peripheral CD8+ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma
Cytokine concentrations in pediatric primary mediastinal large B-cell lymphoma correlate with disease extent and outcome
Nonanemic iron deficiency in pregnancy: a cross-sectional study of prevalence and predictors
Salvage at molecular relapse: many paths, few signposts
Therapeutic timing and molecular properties influence low-molecular-weight heparin efficacy in murine sepsis
Cytoreduction for MPN-associated splanchnic vein thrombosis
Blinatumomab for pediatric B-ALL in LMICs: promise or peril?
EUVIMED